Cite
HARVARD Citation
Martin Nuñez, I. et al. (n.d.). CP-103 Subcutaneous single-use injection device and intravenous formulations in patients with HER2-positive early breast cancer. European journal of hospital pharmacy. pp. A41-A42. [Online].